Results 211 to 220 of about 607,470 (403)

Intricate Regulation of Sphingolipid Biosynthesis: An In‐Depth Look Into ORMDL‐Mediated Regulation of Serine Palmitoyltransferase

open access: yesBioEssays, EarlyView.
Multiple enzymes play a crucial role in regulating the biosynthesis of de novo sphingolipids. This regulation starts with the rate‐limiting enzyme, serine palmitoyltransferase (SPT), which catalyzes the first step of the pathway. Disruptions in this regulatory process can lead to serious diseases.
Usha Mahawar, Binks Wattenberg
wiley   +1 more source

Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria.

open access: yesInternational Journal of Cardiology, 2020
D. Corrado   +25 more
semanticscholar   +1 more source

Pathological Disulfide Bond Crosslinking: Molecular Insights into Amyloidogenesis and Diseases Progression

open access: yesChemBioChem, EarlyView.
This review explores pathological disulfide‐crosslinking as a key driver of amyloidogenic protein misfolding and aggregation. Oxidative and ER stress pathways contributing to disease progression are discussed and emerging therapeutic strategies targeting disulfide‐linked aggregates in neurodegenerative and systemic amyloid diseases are examined ...
Dong Min Kang   +4 more
wiley   +1 more source

Short-term Heart Rate Turbulence Analysis Versus Variability and Baroreceptor Sensitivity in Patients With Dilated Cardiomyopathy [PDF]

open access: yes, 2004
New methods for the analysis of arrhythmias and their hemodynamic consequences have been applied in risk stratification, in particular to patients after myocardial infarction.
Bauernschmitt, Robert   +4 more
core   +1 more source

Treatment With Phosphodiesterase 5 Inhibitors and Long‐Term Outcomes in Patients Undergoing Coronary Angiography and Cardiac Catheterization

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The effects of phosphodiesterase 5 (PDE5) inhibitors on the incidence of long‐term outcomes in patients with cardiovascular disease are not well understood. Objective: We studied the association between PDE5 inhibitor therapy and the incidence of adverse cardiovascular major adverse cardiovascular events (MACE) in patients ...
Sumon Roy   +5 more
wiley   +1 more source

Enzymic analysis of endomyocardial biopsy specimens from patients with cardiomyopathies. [PDF]

open access: bronze, 1977
T. J. Peters   +6 more
openalex   +1 more source

A Road Less Traveled: Successful Alcohol Septal Ablation via an Aberrant Septal Coronary Artery in Hypertrophic Obstructive Cardiomyopathy

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Alcohol septal ablation (ASA) is a minimally invasive treatment option for patients with hypertrophic obstructive cardiomyopathy (HOCM) who remain symptomatic despite medical treatment and are either poor surgical candidates or prefer a less invasive approach.
Vishnu Bharani   +3 more
wiley   +1 more source

Familial centronuclear myopathy associated with 'cardiomyopathy'. [PDF]

open access: bronze, 1976
W Verhiest   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy